Abstract:alpha-Conotoxins are small disulfide-constrained peptides from cone snails that act as antagonists at specific subtypes of nicotinic acetylcholine receptors (nAChRs). The 13-residue peptide alpha-conotoxin RgIA (alpha-RgIA) is a member of the alpha-4,3 family of alpha-conotoxins and selectively blocks the alpha 9 alpha 10 nAChR subtype, in contrast to another well-characterized member of this family, alpha-Conotoxin ImI (alpha-ImI), which is a potent inhibitor of the alpha 7 and alpha 3 beta 2 nAChR subtypes. In this study, we have altered side chains in both the four-residue and the three-residue loops of alpha-RgIA, and have modified its C-terminus. The effects of these changes on activity against alpha 9 alpha 10 and alpha 7 nAChRs were measured; the solution structures of alpha-RgIA and its Y10W, D5E, and P6V analogues were determined from NMR data; and resonance assignments were made for alpha-RgIA [R9A]. The structures for alpha-RglA and its three analogues were well defined, except at the chain termini. Comparison of these structures with reported structures of alpha-ImI reveals a common two-loop backbone architecture within the alpha-4,3 family, but with variations in side-chain solvent accessibility and orientation. Asp5, Pro6, and Arg7 in loop 1 are critical for blockade of both the alpha 9 alpha 10 and the alpha 7 subtypes. In loop 2, alpha-RgIA [Y10W] had activity near that of wild-type alpha-RgIA, with high potency for 000 and low potency for alpha 7, and had a structure similar to that of wild type. By contrast, Arg9 in loop 2 is critical for specific binding to the alpha 9 alpha 10 subtype, probably because it is larger and more solvent accessible than Ala9 in alpha-IMI. Our findings contribute to a better understanding of the molecular basis for antagonism of the alpha 9 alpha 10 nAChR subtype, which is a target for the development of analgesics for the treatment of chronic neuropathic pain. (C) 2008 Elsevier Ltd. All rights reserved.

Aspartic acid mutagenesis of αO-Conotoxin GeXIVA isomers reveals arginine residues crucial for inhibition of the α9α10 nicotinic acetylcholine receptor

Structure-Activity Relationships of Alanine Scan Mutants O-Conotoxins GeXIVA[1,2] and GeXIVA[1,4]

Structure-Activity Relationships of Alanine Scan Mutants αO-Conotoxins GeXIVA and GeXIVA

Αo-Conotoxin GeXIVA Disulfide Bond Isomers Exhibit Differential Sensitivity for Various Nicotinic Acetylcholine Receptors but Retain Potency and Selectivity for the Human Α9α10 Subtype

Cloning, Synthesis, and Characterization of Αo-Conotoxin GeXIVA, a Potent Α9α10 Nicotinic Acetylcholine Receptor Antagonist

Structure and Activity Studies of Disulfide-Deficient Analogues of Αo-Conotoxin GeXIVA.

Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor

Conotoxin Αd-Gexxa Utilizes a Novel Strategy to Antagonize Nicotinic Acetylcholine Receptors.

Alanine-Scanning Mutagenesis of Α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor

Substitution of D-Arginine at Position 11 of Α-Rgia Potently Inhibits Α7 Nicotinic Acetylcholine Receptor.

Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist.

Dual Antagonism of Α9α10 Nachr and GABAB Receptor-Coupled CaV2.2 Channels by an Analgesic Αo-Conotoxin Analogue.

Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human Α9α10 Nicotinic Acetylcholine Receptor.

N-Terminal Capping of the αO-Conotoxin Analogue GeX-2 Improves the Serum Stability and Selectivity toward the Human α9α10 Nicotinic Acetylcholine Receptor

d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability.

Novel Αo-Conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment.

Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.

Discovery and Structural and Functional Characterization of a Novel A-Superfamily Conotoxin Targeting Α9α10 Nicotinic Acetylcholine Receptor

Single Amino Acid Substitution in Loop1 Switches the Selectivity of α-Conotoxin RegIIA towards the α7 Nicotinic Acetylcholine Receptor

Α-Conotoxin [s9a]txid Potently Discriminates Between Α3β4 and Α6/α3β4 Nicotinic Acetylcholine Receptors

Alpha-Rgia, A Novel Conotoxin That Blocks The Alpha 9 Alpha 10 Nachr: Structure And Identification Of Key Receptor-Binding Residues